Literature DB >> 28803208

N-glucuronidation catalyzed by UGT1A4 and UGT2B10 in human liver microsomes: Assay optimization and substrate identification.

Danyi Lu1, Qian Xie2, Baojian Wu3.   

Abstract

N-glucuronidation is an important pathway for metabolism and disposition of tertiary amines in humans. This reaction is mainly catalyzed by the enzymes UGT1A4 and UGT2B10. However, the metabolic patterns of UGT1A4- and UGT2B10-mediated N-glucuronidation are not fully clear. In this study, we first optimized in vitro reaction conditions for N-glucuronidation by using specific substrates (i.e., trifluoperazine for UGT1A4, cotinine and amitriptyline for UGT2B10). Furthermore, we found that hepatic N-glucuronidation showed significant species differences. In addition, UGT1A4 and UGT2B10 were primarily responsible for N-glucuronidation of many tertiary amines, including asenapine, loxapine, clozapine, chlorpromazine, dothiepin, doxepin, mirtazapine, mianserin, chlorcyclizine, cyclizine, promethazine, cyclobenzaprine, imatinib, retrorsine, strychnine and brucine. In conclusion, this study provides an in vitro assay system for evaluating N-glucuronidation of amines. Also, UGT1A4- and UGT2B10-mediated N-glucuronidation might play significant roles in metabolism and detoxification of tertiary amines in humans.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  N-glucuronidation; Species differences; Tertiary amines; UGT1A4; UGT2B10

Mesh:

Substances:

Year:  2017        PMID: 28803208     DOI: 10.1016/j.jpba.2017.07.037

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Post-transcriptional Regulation of UGT2B10 Hepatic Expression and Activity by Alternative Splicing.

Authors:  Adrien Labriet; Eric P Allain; Michèle Rouleau; Yannick Audet-Delage; Lyne Villeneuve; Chantal Guillemette
Journal:  Drug Metab Dispos       Date:  2018-02-09       Impact factor: 3.922

2.  Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver.

Authors:  Aimee K Sutliff; Jian Shi; Christy J W Watson; Martina S Hunt; Gang Chen; Hao-Jie Zhu; Philip Lazarus
Journal:  Mol Pharmacol       Date:  2019-09-25       Impact factor: 4.436

Review 3.  Transdermal Asenapine in Schizophrenia: A Systematic Review.

Authors:  Brennan Carrithers; Rif S El-Mallakh
Journal:  Patient Prefer Adherence       Date:  2020-08-25       Impact factor: 2.711

4.  Possible pharmacogenetic factors in clozapine treatment failure: a case report.

Authors:  Eromona Whiskey; Graziella Romano; Matilda Elliott; Malcolm Campbell; Cholan Anandarajah; David Taylor; Koravangattu Valsraj
Journal:  Ther Adv Psychopharmacol       Date:  2021-07-22

5.  A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation.

Authors:  Shannon Robin; Khalil Ben Hassine; Tiago Nava; Chakradhara Rao S Uppugunduri; Marc Ansari; Jayaraman Muthukumaran; Simona Jurkovic Mlakar; Maja Krajinovic
Journal:  BMC Mol Cell Biol       Date:  2022-01-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.